ZITUVIMET XR

Generic: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Zydus Pharmaceuticals USA Inc.Manufacturer
ORALRoute
SITAGLIPTINActive Substance
2024-07-18Original Approval

ZITUVIMET XR is FDA application NDA216778, sponsored by ZYDUS LIFESCIENCES. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
5 reports
2
COMPLETED SUICIDE
4 reports
3
DIZZINESS
4 reports
4
PAIN IN EXTREMITY
4 reports
5
ABNORMAL DREAMS
3 reports
6
DIARRHOEA
3 reports
7
MALAISE
3 reports
8
NAUSEA
3 reports
9
SOMNOLENCE
3 reports
10
ANXIETY
2 reports